Taisho Pharmaceutical Co., Ltd.
Clinical trials sponsored by Taisho Pharmaceutical Co., Ltd., explained in plain language.
-
New drug helps dialysis patients manage dangerous phosphorus levels
Disease control CompletedThis study tested a new drug called TS-172 in 101 adults on hemodialysis who had high phosphorus levels. The goal was to see if the drug could help bring phosphorus down to a safer range. Participants took TS-172 or a placebo for several weeks, and researchers measured changes in…
Phase: PHASE3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Healthy men test drug timing for mineral excretion
Knowledge-focused CompletedThis study looked at how taking TS-172 at different times of day changes the amount of phosphorus and sodium released in urine. It involved 16 healthy Japanese men aged 18-39. The goal was to understand the drug's effects, not to treat any disease.
Phase: PHASE1 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC